Biomarin Pharmaceutical is Pharmaceutical and Biotechnology Company with headquarters is in California, USA.
It develops innovate therapies and life-threatening rare diseases and medical conditions.It consists of seven commercial products for the treatment of various diseases.
As on 2022, Biomarin Pharmaceutical has 3,082 employees.
Biomarin Pharmaceutical annual revenue generated for period ending Dec-2022 was 2,096 million USD.
Biomarin Pharmaceutical GGross profit generating for the period of ending 2022 was 141 million USD.